Jeremy Morgan
Director/Board Member chez ARECOR THERAPEUTICS PLC
Fortune : 48 050 $ au 31/03/2024
Profil
Jeremy Lewis Morgan currently works at Arecor Therapeutics Plc, as Independent Non-Executive Director and Kyowa Kirin International Plc, as Senior Vice President-Commercial.
Mr. Morgan also formerly worked at PHMR Ltd., as Non-Executive Chairman from 2019 to 2020 and Eli Lilly & Co., as Vice President-International Diabetes from 2014 to 2017.
Mr. Morgan received his undergraduate degree from Coventry University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
0,09% | 04/08/2022 | 27 169 ( 0,09% ) | 48 050 $ | 31/03/2024 |
Postes actifs de Jeremy Morgan
| Sociétés | Poste | Début |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Director/Board Member | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Corporate Officer/Principal | - |
Anciens postes connus de Jeremy Morgan
| Sociétés | Poste | Fin |
|---|---|---|
PHMR Ltd.
 PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The private company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Chairman | 01/01/2020 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2017 |
Formation de Jeremy Morgan
| Coventry University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ARECOR THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
PHMR Ltd.
PHMR Ltd. Information Technology ServicesTechnology Services Part of UDG Healthcare Ltd. (Dublin), PHMR Ltd. is a healthcare consulting British company that specializes in insight-enabled pricing and market access approaches to ensure successful product launch and life-cycle management. The private company is based in London, UK. The company helps its clients in the healthcare industries build value for their products by using academically-proven analytical methods to find and form clinical, economic, and humanistic evidence. PHMR is an international team of highly qualified health economists and research scientists. The company was founded by Mark Ratcliffe, who has been the CEO since incorporation. PHMR was acquired by UDG Healthcare Ltd. (Dublin) on January 26, 2021 for $43.75 million. | Technology Services |
